Form 4: CompoSecure Director Joseph DeAngelo Granted Stock Options

Sentiment:

Director Compensation Disclosure


CompoSecure, Inc. Director Joseph J. DeAngelo was granted 21,074 stock options with an exercise price of $13.68, vesting over four years.

Summary

  • Joseph J. DeAngelo, a Director of CompoSecure, Inc. (CMPO), acquired 21,074 stock options on May 28, 2025.
  • The exercise price for these stock options is $13.68 per share.
  • The options are set to vest in equal annual installments of 25% each, beginning on May 28, 2026, and continuing on the first, second, and third anniversaries thereafter.
  • The expiration date for these stock options is May 28, 2035.
  • Following this transaction, Mr. DeAngelo directly beneficially owns 21,074 stock options.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a positive event as it aligns the director's interests with shareholder value creation, but it is a routine compensation disclosure rather than a significant operational or financial announcement.

Positives

  • The grant of stock options to Director Joseph J. DeAngelo aligns his financial interests with those of the shareholders, incentivizing long-term company performance.
  • The vesting schedule over four years encourages sustained commitment and performance from the director.

Negatives

  • No direct negative implications are apparent from this routine compensation disclosure.

Risks

  • No specific risks are mentioned in this Form 4 filing.

Future Outlook

The vesting schedule indicates that the stock options will become exercisable over the next four years, providing a long-term incentive for the director.

Industry Context

Granting stock options to directors is a common practice in corporate governance across various industries, serving as a form of equity-based compensation to align director interests with shareholder value creation.

Comparison to Industry Standards

  • The grant of stock options to a director, with a multi-year vesting schedule and a 10-year expiration, is a standard form of equity compensation in publicly traded companies.
  • This practice is consistent with compensation structures observed in companies of similar size and industry, such as those in the financial technology or secure credentialing sectors. Specific comparable companies or projects are not detailed in this filing, but the general structure aligns with typical director compensation packages.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure of Insider TransactionThis filing is a disclosure of an insider transaction (grant of stock options to a director), which is a component of corporate governance transparency.05/28/2025Enhances transparency regarding director compensation and alignment of interests.

Related Party Transactions

  • The grant of stock options to Joseph J. DeAngelo, a Director of CompoSecure, Inc., constitutes a transaction with a related party.

Stakeholder Impact

  • Shareholders: The grant of options aims to align the director's interests with shareholder value creation, potentially leading to improved long-term performance.

Next Steps

  • The stock options will vest in annual installments over the next four years, starting May 28, 2026.

Key Dates

DateDescription
05/28/2025Date of transaction (acquisition of stock options).
05/28/2026First vesting date (25% of options vest).
05/28/2027Second vesting date (additional 25% of options vest).
05/28/2028Third vesting date (additional 25% of options vest).
05/28/2029Fourth vesting date (final 25% of options vest).
05/30/2025Date the Form 4 was signed by attorney-in-fact.
05/28/2035Expiration date of the stock options.

Keywords

CompoSecure, CMPO, Stock Options, Director Compensation, Insider Transaction, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.